注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-Complement C5 Reference Antibody (Pexelizumab)   

Anti-Complement C5 Reference Antibody (Pexelizumab)

     
  • 0 - Anti-Complement C5 Reference Antibody (Pexelizumab) APR11472
    Anti-Complement C5 Reference Antibody (Pexelizumab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-Complement C5 Reference Antibody (Pexelizumab) APR11472
    The purity of Anti-Complement C5 Reference Antibody (Pexelizumab) is 99.7%, determined by SEC-HPLC.
  • 0 - Anti-Complement C5 Reference Antibody (Pexelizumab) APR11472
    Immobilized Human Complement C5 Protein, It’s target at 3 µg/mL can bind Pexelizumab(ScFv-noTag), EC50= 1.235 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P01031
Reactivity Human
Clonality Monoclonal
Isotype ScFv-C-6His
Calculated MW 188305 Da
Additional Information
Target/Specificity Complement C5
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name C5 {ECO:0000303|PubMed:1984448, ECO:0000312|HGNC:HGNC:1331}
Function Precursor of the C5a anaphylatoxin and complement C5b components of the complement pathways, which consist in a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system (PubMed:12878586, PubMed:18204047, PubMed:30643019, PubMed:6554279). Activated downstream of classical, alternative, lectin and GZMK complement pathways (PubMed:12878586, PubMed:18204047, PubMed:30643019, PubMed:39914456, PubMed:39814882, PubMed:6554279).
Cellular Location Secreted. [C5a anaphylatoxin]: Secreted
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价